Co-Founder, Vice President for Business Development
Mr. Kinder has a 45-year career in electronics that spans early µprocessor designs and work on the A10 Thunderbolt (Warthog) in 1976, and data loggers, embedded controls, and robotics from 1979-1990. Since 1990 he has been involved in the behavioral instrumentation industry where he worked on the first commercial startle system in 1992 and in 1997 he founded Kinder Scientific where he serves as President. Mr. Kinder and Dr. Turner have worked together for over 10 years in the development of novel assays for measuring hearing loss and tinnitus, which has resulted in two US Patents (8,088,077 and 8,888,712)
OtoScience Labs (OSL) is devoted to increasing awareness of and developing solutions for the problems of noise, hearing loss, and tinnitus. We are inventors and developers of technology to better measure hearing loss and tinnitus in animal models and humans. OSL is the exclusive licensee of technology from SIU School of Medicine (US Patents 8,088,077 and 8,888,712) and research on OSL’s human tinnitus test is currently funded by the US Department of Defense. OSL brings decades of experience to the field of hearing research. OSL specializes in contract research in ototoxicity and noise consulting services for biomedical research facilities and industry.
OSL is driven by the highest quality, automated measurement. Our motto is that if you can’t measure it you certainly can’t understand it. Whether it is tinnitus, hearing loss, noise and ultrasonic noise, or vibration. Our work is driven by providing measurements to inform decisions.
Dr. Turner received his PhD in 1999 in auditory neuroscience studying mouse hearing under Dr. James Willott. Dr. Turner has authored several dozen scientific publications related to hearing and has received grant funding from National Institutes of Health, Tinnitus Research Consortium, and the US Department of Defense. He is a member of the Society for Neuroscience, Association for Research in Otolaryngology, American Association for Laboratory Animal Science, and American Tinnitus Association. He was recently appointed as a member of the American Tinnitus Association’s Scientific Advisory Committee. Click Here to view Dr. Turner's CV.
PhD, Grants and Regulatory Affairs
Dr. Puczynski provides regulatory support and guidance for clinical studies being conducted by OtoScience Labs (OSL). She also assists with grant planning, development and implementation. Dr. Puczynski has more than 25 years experience leading clinical research programs at various academic institutions and has administered many clinical trials funded by NIH, DoD and Industry. She is currently assisting OSL with a multi-site evaluation of a device for the objective assessment of tinnitus in humans.
“….when you can measure what you are speaking about and express it in numbers you know something about it; but when you cannot measure it, when you cannot express it in numbers, your knowledge is of a meagre and unsatisfactory kind: it may be the beginning of knowledge, but you have scarcely, in your thoughts, advanced to the stage of science, whatever the matter may be.”
Lord Kelvin 1891
John V. Schloss
PhD, CEO and Pharmaceutical Development
Dr. Schloss has a 35-year career in biological and pharmaceutical science. He has held both academic and industry appointments as Chief Executive Officer for a biotech startup; Research Supervisor in the Central Research Department of E. I. Du Pont de Nemours & Co; Secretary (elected position) for the Biological Chemistry Division of the American Chemical Society; Director of Chemistry for a biotech startup; Chair of several basic science departments devoted to pharmaceutical research, including the Department of Medicinal Chemistry at the University of Kansas. He has served as Principal Investigator
for numerous peer-reviewed grants from the National Institutes of Health, the Office of Naval Research, the Maine Technology Institute, the U.S.-Israel Binational Science Foundation, Congressionally Directed Medical Research Programs (CDMRP, U.S. Army) and the Pfeiffer Research Foundation. His current focus is on use of objective measures of hearing loss and tinnitus for the development of new therapeutics for hearing disorders.